Development and Optimization of Candesartan Cilexitil-Loaded Ethosomal Gel for Enhanced Delivery: Improving Transdermal Therapeutics Via Box‒Behnken Statistical Design
- 16 January 2026
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (2) , 136
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Development of Candesartan Cilexetil-sodium Carbonate Anhydrate-mesoporous Silica Solid Dispersion in Polymer-free SystemPharmaceutical Research, 2025
- Engineering colloidal systems for cell manipulation, delivery, and trackingAdvances in Colloid and Interface Science, 2025
- Development and optimization of film forming non-pressurized liquid bandage for wound healing by Box-Behnken statistical designSaudi Pharmaceutical Journal, 2023
- Development and optimization of candesartan cilexetil nasal gel for accentuated intranasal delivery using central composite designMaterials Today: Proceedings, 2022
- Polymeric ethosomal gel loaded with nimodipine: Optimisation, pharmacokinetic and histopathological analysisSaudi Pharmaceutical Journal, 2022
- Ethosomes: A novel drug carrierAnnals of Medicine & Surgery, 2022
- Enhancement strategies for transdermal drug delivery systems: current trends and applicationsDrug Delivery and Translational Research, 2021
- A novel nano-carrier transdermal gel against inflammationInternational Journal of Pharmaceutics, 2014
- Transdermal drug deliveryNature Biotechnology, 2008
- Colloidal drug carriers: achievements and perspectivesCellular and Molecular Life Sciences, 2003